Group One Trading’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.24M | Sell |
38,200
-87,300
| -70% | -$2.81M | ﹤0.01% | 2501 |
|
|
2025
Q4 | $4.42M | Sell |
125,500
-23,200
| -16% | -$822K | 0.01% | 1617 |
|
|
2025
Q3 | $3.91M | Buy |
148,700
+40,300
| +37% | +$1.2M | 0.01% | 1706 |
|
|
2025
Q2 | $2.87M | Buy |
108,400
+3,900
| +4% | +$103K | 0.01% | 1799 |
|
|
2025
Q1 | $2.52M | Sell |
104,500
-23,700
| -18% | -$749K | 0.01% | 1620 |
|
|
2024
Q4 | $5.16M | Buy |
128,200
+8,500
| +7% | +$485K | 0.01% | 1145 |
|
|
2024
Q3 | $7.58M | Buy |
119,700
+57,300
| +92% | +$3.36M | 0.02% | 748 |
|
|
2024
Q2 | $3.31M | Sell |
62,400
-29,400
| -32% | -$1.93M | 0.01% | 1060 |
|
|
2024
Q1 | $7.53M | Sell |
91,800
-233,300
| -72% | -$10.4M | 0.03% | 573 |
|
|
2023
Q4 | $6.05M | Buy |
325,100
+268,100
| +470% | +$3.51M | 0.02% | 995 |
|
|
2023
Q3 | $631K | Sell |
57,000
-104,500
| -65% | -$1.49M | ﹤0.01% | 2690 |
|
|
2023
Q2 | $2.62M | Buy |
161,500
+400
| +0.2% | +$8.38K | 0.01% | 1459 |
|
|
2023
Q1 | $2.68M | Buy |
161,100
+71,200
| +79% | +$735K | 0.01% | 1294 |
|
|
2022
Q4 | $845K | Buy |
89,900
+52,400
| +140% | +$234K | ﹤0.01% | 2579 |
|
|
2022
Q3 | $102K | Sell |
37,500
-800
| -2% | -$2.62K | ﹤0.01% | 4763 |
|
|
2022
Q2 | $111K | Sell |
38,300
-7,500
| -16% | -$18.6K | ﹤0.01% | 4888 |
|
|
2022
Q1 | $137K | Buy |
45,800
+3,500
| +8% | +$12.6K | ﹤0.01% | 5187 |
|
|
2021
Q4 | $195K | Buy |
42,300
+4,600
| +12% | +$25.8K | ﹤0.01% | 5111 |
|
|
2021
Q3 | $237K | Sell |
37,700
-4,100
| -10% | -$25.3K | ﹤0.01% | 4995 |
|
|
2021
Q2 | $250K | Buy |
41,800
+7,200
| +21% | +$42.7K | ﹤0.01% | 4986 |
|
|
2021
Q1 | $219K | Sell |
34,600
-37,500
| -52% | -$264K | ﹤0.01% | 4941 |
|
|
2020
Q4 | $406K | Buy |
72,100
+14,500
| +25% | +$87.8K | ﹤0.01% | 3458 |
|
|
2020
Q3 | $335K | Sell |
57,600
-17,600
| -23% | -$121K | ﹤0.01% | 3216 |
|
|
2020
Q2 | $542K | Sell |
75,200
-2,300
| -3% | -$15.3K | ﹤0.01% | 2564 |
|
|
2020
Q1 | $363K | Sell |
77,500
-49,900
| -39% | -$307K | ﹤0.01% | 2283 |
|
|
2019
Q4 | $1.02M | Buy |
127,400
+18,700
| +17% | +$136K | 0.01% | 1849 |
|
|
2019
Q3 | $748K | Buy |
108,700
+6,300
| +6% | +$46.8K | 0.01% | 1999 |
|
|
2019
Q2 | $850K | Sell |
102,400
-64,700
| -39% | -$553K | 0.01% | 1707 |
|
|
2019
Q1 | $1.66M | Sell |
167,100
-84,100
| -33% | -$704K | 0.02% | 1055 |
|
|
2018
Q4 | $1.92M | Sell |
251,200
-100,100
| -28% | -$1.2M | 0.02% | 1064 |
|
|
2018
Q3 | $6.12M | Buy |
351,300
+117,100
| +50% | +$1.39M | 0.05% | 479 |
|
|
2018
Q2 | $2.22M | Buy |
234,200
+212,400
| +974% | +$1.41M | 0.02% | 1065 |
|
|
2018
Q1 | $95K | Buy |
+21,800
| New | +$121K | ﹤0.01% | 3283 |
|
Other funds holding VKTX
VCM
VPM
Group One Trading's VKTX Position: Q1 2026 in Review
Group One Trading increased its Viking Therapeutics (VKTX) stake by 47% in Q1 2026, buying an estimated $2.19M and bringing the position to 211,817 shares worth $6.89M. The position accounts for 0.01% of the portfolio, ranked #1077.
Group One Trading first reported a position in VKTX in Q1 2018 and has held it in 33 quarters since. The position peaked at $16.7M in Q3 2024. 410 funds tracked by Wall St. Rank hold VKTX as of Q1 2026.
- Group One Trading held 211,817 shares of Viking Therapeutics worth $6.89M as of Q1 2026.
- Group One Trading bought 68,202 Viking Therapeutics shares in Q1 2026, an estimated $2.19M.
- Viking Therapeutics made up 0.01% of Group One Trading's portfolio in Q1 2026, its #1077 holding.
- Group One Trading first reported a position in Viking Therapeutics in Q1 2018 and has held it in 33 quarters since.
- Group One Trading's Viking Therapeutics position peaked at $16.7M in Q3 2024.
- 410 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.